Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
11/2001
11/28/2001EP0918745B1 Catalytic preparation process of n-acylglycine derivatives
11/28/2001EP0906268B1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
11/28/2001EP0660716B1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/27/2001US6323202 Benzamide substitutes with ketone compounds as enzyme inhibitors
11/22/2001WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001WO2001087823A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
11/22/2001WO2001087822A1 Novel phenyl-propargylether derivatives
11/22/2001WO2001087293A1 -secretase inhibitors
11/22/2001WO2000035879A8 3-phenyl-2,6-dioxopiperidin-3-yl propionamide derivatives and method for preparing same
11/22/2001US20010044547 From l-mannonic-gamma-lactone intermediates; for prophylaxis of HIV/AIDS HIV
11/22/2001US20010044420 Treatment of mammalian cancer
11/22/2001DE10123132A1 Molecular arrangement with geometrically regular structure, useful e.g. for quantum computer, grating or molecular sieve, consists of adducts of cage molecules linked by pairs of key-lock addends
11/22/2001CA2410077A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001CA2409740A1 Novel aryl, alkenyl, and alkynyl 4-dedimethylaminotetracycline desrivatives
11/22/2001CA2407088A1 Beta-secretase inhibitors
11/21/2001EP1156036A2 Compounds with electron donor and electron acceptor functionality
11/21/2001EP1156032A1 Optically active amino acid derivatives and processes for the preparation of the same
11/21/2001EP1155138A2 Method for preparing optically active 3,3,3-trifluoromethyl-2-alkyl propionic acid derivatives
11/21/2001EP1154991A1 Salicylamide-lanthanide complexes for use as luminescent markers
11/21/2001EP1154990A1 Phthalamide-lanthanide complexes for use as luminescent markers
11/21/2001EP1154989A1 Vanilloid analogues containing resiniferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof
11/21/2001EP1154988A1 Mevinolin derivatives
11/21/2001EP1154987A1 Phenylalaninol derivatives
11/21/2001EP1154984A1 Inhibitors for uptake of serotonine, dopamine or norepinephrine
11/21/2001EP0952974B1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
11/21/2001CN1323291A Diaminopropionic acid derivatives
11/21/2001CN1075060C Alkoxy-alkyl-substituted 1-H-3-aryl-pyrrolidine-2.4-diones uses as herbicides and pesticides
11/20/2001US6320074 In vivo modulation of lipid metabolism, skin-related processes, autoimmune diseases, fatty acid metabolism, malignant cell development, premalignant lesions, or programmed cell death
11/20/2001US6320047 Substituted aryl or heteroarylamides having retinoid-like biological activity
11/20/2001US6320017 Polyamide oligomers
11/20/2001US6319940 Carbanilides used as pesticides
11/20/2001US6319930 Substituted dimeric compounds
11/18/2001CA2347898A1 Compounds with electron donor and electron acceptor functionality
11/15/2001WO2000051548A3 COMPOSITIONS AND METHODS FOR THEIR PREPARATION FROM $i(LEPIDIUM)
11/15/2001US20010041814 Phthalic acid diamide derivatives fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
11/15/2001US20010041798 Processes and intermediates in the synthesis of 5-(3-{exo-bicyclo{2.2.1}hept-2-yloxy]-4-methoxyphenyl)-3,4,5,6- tetrahydropyrimidin-2(1H)-one
11/14/2001EP0984687B1 Fungicidal mixtures
11/14/2001CN1322196A Naphthalenecaarboxamides as tachykinin receptor antagonists
11/13/2001US6316503 For therapy of disease states associated with cholesterol metabolism such as atherosclerosis and hypercholesterolemia
11/13/2001US6316455 Method of improving the effectiveness of a cytotoxic drug or radiotherapy using a quinazolinone compound
11/13/2001US6316009 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharamaceutical and cosmetic compositions containing same
11/08/2001WO2001084714A2 Molecular arrangement with a structural configuration and use thereof for quantum-mechanical information processing
11/08/2001WO2001083445A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/08/2001WO2001082925A1 Melanin concentrating hormone antagonists
11/08/2001US20010039293 4((4-chloro-3-hydroxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro -naphathalene-2-carbonyl)-amino)-2,6-difluoro-benzoic acid or its esters or salts used as agonists of alpha-retinoid receptors (=raralpha)
11/08/2001US20010039279 Diamide compounds and compositions containing the same
11/08/2001US20010039258 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and to form a subcutaneously deliverable supramolecular complex, subcutaneously administering complex
11/08/2001US20010039035 Enhancing the reaction of a conjugate comprising a detectably labeled phenol substrate with a peroxidase by reacting in the presence of an inorganic compound e.g. NACl, and an organic compound, e.g. p-iodophenol; signal amplification immunoassay
11/08/2001CA2377629A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/07/2001EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/07/2001CN1321150A Amide derivs. useful as inhibitors of production of cytokines
11/06/2001US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment
11/06/2001US6313177 As antiviral agents
11/06/2001US6313150 α-substituted phenylacetic acid derivative, its production and agricultural fungicide containing it
11/06/2001US6313142 Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
11/06/2001US6313122 As inhibitors of factor xa and are used as anticoagulants in mammals
11/06/2001US6313088 Carriers used to deliver various active agents through various biological, chemical, and physical barriers
11/01/2001WO2001081297A1 Novel amino acid derivatives, preparation method, compositions containing same and uses thereof as sunscreens
11/01/2001WO2001081295A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001WO2001030736A3 Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors
11/01/2001US20010035520 Acrylated ester
11/01/2001CA2406272A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001CA2375068A1 Novel amino acid derivatives, preparation method, compositions containing same and uses thereof as sunscreens
10/2001
10/31/2001EP1149067A1 7-aryl-6(z)heptatrienoic acid retinamides as apoptosis inducing compounds and their use as anti-cancer agents
10/31/2001EP1149066A1 Method of preparing alkylated salicylamides
10/31/2001EP0888380B1 Process for alkylating and smiles rearrangement of hydroxy aromatics
10/30/2001US6310247 7-aryl-6(Z)-heptatrienoic acid retinamides
10/30/2001US6310246 Fluorovinloxyacetamides, process for preparing same and herbicidal composition comprising same
10/30/2001US6310245 3-aminocarbonyl/3-aminothiocarbonyl-substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect
10/30/2001US6310244 Photocleavable and acid cleavable linkers for combinatorial chemistry
10/30/2001US6310243 Benzene compounds in which 3 non-adjacent ring atoms are substituted with iodine, 2 of the remaining ring atoms are amide substituted with hydroxy and the other remaining ring atom is a non-amide, hydroxy-substituted nonionic moiety
10/30/2001US6310087 Treating gastric or duodenal ulcer, osteoporosis, constipation, renal disorders, sexual dysfunction, baldness, diabetes, cancer and disorder of immune regulation
10/30/2001US6310078 Substituted amino acids as erythropoietin mimetics
10/30/2001CA2123101C Nitroxyalkylamide derivative
10/25/2001WO2001079244A1 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
10/25/2001US20010034371 Antidiabetic agents
10/25/2001US20010034341 Bactericides
10/24/2001EP1148048A2 Polyaromatic antiviral compositions
10/24/2001EP1147214A1 A novel method for designing protein kinase inhibitors
10/24/2001EP0900190B1 Novel acetals of hydroxy carboxylic acids, derivatives thereof and process for the preparation thereof
10/24/2001CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/24/2001CN1319086A Anthranilic acid derivatives
10/24/2001CN1318544A Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent
10/23/2001US6307087 Ligands for metals and improved metal-catalyzed processes based thereon
10/23/2001US6307044 Process for the preparation of macrocyclic metalloprotease inhibitors
10/23/2001US6306959 Rapid purification by polymer supported quench
10/23/2001US6306950 Improving the heat resistance of the title resin by including titanium dioxide having a zinc content of <0.1%; also includes an impact modifier, a stabilizer and a lubricant; pipes for conveying hot water; extrusion; discoloration inhibition
10/23/2001US6306912 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
10/23/2001US6306463 Citric acid tri-alkylamide surfactants
10/23/2001CA2222657C Intermediates in preparation of new phenylethanolaminomethyltetralins
10/18/2001WO2001077069A1 Naphthamide neurokinin antagonists for use as medicaments
10/18/2001WO2001038294A3 Methods for producing 2-(2-hydroxyphenyl)-2-(alkoxyimino)-n-methylacetamide derivatives
10/18/2001US20010031895 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines
10/18/2001US20010031874 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/17/2001EP1144370A2 Thyroid receptor ligands
10/17/2001EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001EP0946497B1 Process for the preparation of nmda antagonists
10/17/2001CN1318054A Novel compounds
10/17/2001CN1317482A 2,4-substituted phenoxypropanamide compounds and preparing process and application thereof
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 157